Shulin Wei, Mingxing Li, Qin Wang, Yueshui Zhao, Fukuan Du, Yu Chen, Shuai Deng, Jing Shen, Ke Wu, Jiayue Yang, Yuhong Sun, Li Gu, Xiaobing Li, Wanping Li, Meijuan Chen, Xiao Ling, Lei Yu, Zhangang Xiao, Lishu Dong, Xu Wu
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract, which has a high recurrence rate and is incurable due to a lack of effective treatment. Mesenchymal stromal cells (MSCs) are a class of pluripotent stem cells that have recently received a lot of attention due to their strong self-renewal ability and immunomodulatory effects, and a large number of experimental and clinical models have confirmed the positive therapeutic effect of MSCs on IBD. In preclinical studies, MSC treatment for IBD relies on MSCs paracrine effects, cell-to-cell contact, and its mediated mitochondrial transfer for immune regulation...
2024: Journal of Inflammation Research